Scienion Receives ISO 9001:2008 Certification
News Feb 19, 2009
Scienion has announced the DIN EN ISO 9001:2008 certification for the development, manufacture and sales of dispensing systems and microarrays.
Scienion claims to be one the first biotech companies that have been certified according to the latest revision of the world’s most widely used standard for quality management systems.
“The ISO certification is an important milestone for Scienion”, says Dr. Holger Eickhoff, CEO of Scienion AG. “I am sure it will further increase the confidence in our high quality technology products for ultra-low volume liquid handling such as our sciFLEXARRAYER product line and our microarray services. And, we are committed to constantly improve our quality management system.”
Certification of conformity to ISO 9001:2008 for the development, manufacture and sales of dispensing systems and microarrays was granted to Dortmund based Scienion by the national certification body TÜV Rheinland on December 18, 2008. The latest ISO 9001:2008 revision was published only a couple of weeks before, on November 14, 2008.
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE